|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
| City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
| City | 515 N. STATE STREET, CHICAGO |
State | IL |
Zip Code | 60654 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
||||||||
| TYPE OF REPORT | 8. Year | 2012 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: George E. Cox III |
Date | 10/19/2012 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding/appropriations for the Agency for Healthcare Research and Quality
Budget Control Act, provisions relating to sequestration
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S. 3187, Food and Drug Administration Safety and Innovation Act, provisions relating to drug shortages, antibiotic incentives, and combating diversion
H.R. 5998, USPSTF Transparency and Accountability Act of 2012, all provisions
H.R. 2119, Ryan Creedon Act of 2011, all provisions
H.R. 3497, MODDERN Cures Act of 2011, all provisions
H.R. 3207, Modernizing Laboratory Test Standards for Patients Act of 2011, all provisions
H.R. 866, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2011, all provisions
H.R. 2182, Generating Antibiotic Incentives Now Act of 2011, all provisions
H.R. 2960, National Diabetes Clinical Care Commission Act, all provisions
H.R. 4384, Patient Safety and Drug Labeling Improvement Act, all provisions
Clinical Registries
ACA Implementation
Insurance Exchanges
Prescription Drug Abuse
Drug diversion/mandatory CME for DEA Registrants/violence prevention
Drug shortages
Flexible Spending Accounts (FSAs)
Delivery and Payment Reform
Personalized Medicine
Health Information Technology
HIPAA Administrative Simplifications
Health Insurance Reform
Medical Licensing Boards and Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), White House Office, Food & Drug Administration (FDA), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 5888, Physician Reentry Demonstration Program Act, all provisions
S. 3245, To extend by 3 years the authorization of the EB-5 Regional Center Program, the E-Verify Program, the Special Immigrant Nonminister Religious Worker Program, and the Conrad State 30 J-1 Visa Waiver Program, provisions relating to J-1 Visa Waiver
Program Reauthorization, Section 4
State Action Doctrine
FTC and Licensure
DOJ/FTC Health Care Antitrust Guidelines
Health Care Market Competition
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC), U.S. SENATE, Justice - Dept of (DOJ), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Cybil |
Roehrenbeck |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 452, Medicare Decisions Accountability Act of 2011, all provisions
S. 668, Health Care Bureaucrats Elimination Act, all provisions
H.R. 5, Protecting Access to Healthcare Act, provisions relating to IPAB Repeal
H.R. 1700, Medicare Patient Empowerment Act, all provisions
S. 1042, Medicare Patient Empowerment Act, all provisions
H.R. 5942, Quality Improvement Organization Program Restoration Act, all provisions
H.R. 3269, Diagnostic Imaging Services Access Protection Act of 2011, all provisions
S. 2347, Diagnostic Imaging Services Access Protection Act of 2012, all provisions
Medicare program - Physician Payment and Delivery Reform
Medicare program - Physician Payment System
Medicare program - 2013 Physician Fee Schedule
Medicare program - Economic Index
Medicare program - Budget Sequestration
Medicare program - Graduate Medical Education
Medicare program - Physician Payment Sunshine Act
Medicare program - SGR Repeal
Medicare program - Resource-based Relative Value Scale/RVS Update Committee
Medicare program - ICD-10
Medicare program - Private Contracting
Medicare program - Physician Quality Reporting System (PQRS)
Medicare program - AMA advocacy priorities
Medicare program - E & M Upcoding
Medicare program - RAC/E&M documentation
Medicare program - Observation care
Medicare program - MoPath codes
Medicare program - E-prescribing
Medicare program - Care coordination codes
Medicare program - Value-Based Modifier (VBM) and Quality & Resource Use Reports (QRUR)
Medicare program - Hospital Out-patient Departments
Medicare program - Physician Quality Reporting System (PQRS) Group Practice Reporting Option (GPRO)
Medicare program - Advance payment
Medicare program - Plan ID
Medicare program - EFT
Medicare program - Advance payment policy
Medicare program - Enrollment
Medicare program - Quality Measure Development and Endorsement
Medicare program - Scope of Practice
Medicare program - AMA perspective on physician payment reform
Medicare program - Bundling proposals
Medicare program - Conditions of Participation
Medicare program - Regulatory Relief
Medicare program - Shared Savings/Accountable Care Organizations
Medicare and Medicaid programs - Public-Private Partnership
Medicare and Medicaid programs - Program Integrity
Medicare and Medicaid programs - Dual Eligibles
Medicare and Medicaid programs - Meaningful Use Stage 2
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Medicare Payment Advisory Commission (MedPAC), Justice - Dept of (DOJ), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
Meeks |
|
|
|
Mari |
Savickis |
|
|
|
Carol |
Vargo |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
|
Debra |
Cohn |
|
|
|
Cybil |
Roehrenbeck |
|
|
|
Kathleen |
Tenoever |
|
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 5, Protecting Access to Healthcare Act, provisions relating to the HEALTH Act
H.R. 3586, Good Samaritan Health Professionals Act of 2011, all provisions
Volunteer physicians - liability licensure issues
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
George |
Cox |
III |
|
|
Liza |
Assatourians |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Payer reimbursement of physicians through credit cards
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Mari |
Savickis |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address | |
||||||
| City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
| City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
5 |
|
||||||
| 2 |
|
6 |
|
||||||
| 3 |
|
7 |
|
||||||
| 4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
DEF |
|
|
|
|
|
|
|
|
TOB |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 3 | 5 |
| 2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 5 | 9 |
| 2 | 6 | 10 |
| 3 | 7 | 11 |
| 4 | 8 | 12 |